2025

Focusing on research and development innovation, actively absorbing cutting-edge technologies and concepts, deeply integrating multidisciplinary knowledge systems, and fully expanding product line layout to cover fields such as medicine, nutrition, etc.

2025

2024

Join hands with the Chinese Academy of Medical Sciences to apply for the Beijing Natural Science Foundation in the forefront of technology and innovation.

2024

2023

Continue to consolidate and improve the construction of marketing network for intestinal bacterial colonization products, and further increase the market share of the products.

2023

2022

Further commercialize the mature intestinal bacterial colonizer products, put them into production and launch them on the market, and sell them online and offline simultaneously.

2022

2021

Combining the new policy and analysis of the big health market, while steadily promoting the optimization of the intestinal bacterial colonization factor project, the company anchored the special medical food market.

2021

2020

In the face of novel coronavirus (SARS CoV-2), the company set up a special expert group to successfully develop and produce a kit for quantitative determination of IgG antibody titer (ELISA).

2020

2019

The intestinal bacterial colonizer project won the first prize in the field of biomedicine in the second China * Jinan New Energy International High Level Talent Innovation and Entrepreneurship Competition.

2019

2018

Through the research of the scientific research team on the raw materials of traditional Chinese medicine, the original formula and production process of intestinal bacterial colonization were successfully obtained.

2018

2017

The establishment of an Australian branch focused on independent life science research and development and basic biotechnology.

2017

2016

Successfully obtained preliminary results and initial experimental data from research on raw materials of traditional Chinese medicine, and initiated major special projects in the field of life science and adjuvant therapy.

2016

2015

Has been awarded various national certifications, such as National High tech Enterprise and ISO9001 Quality Management System Certification.

2015

2014

Based on a mature team of biological science research experts and cooperating with independent technology research and development achievements, we have successfully established a multi-functional professional biological research technology test platform.

2014

2013

Beijing Qianzhao Xinye Technology Biology Co., Ltd. was registered and established, focusing on the research and development of new technologies in the field of life sciences and adjuvant therapy.

2013